Form 4 for TGTX TG THERAPEUTICS, INC.

Accepted 2022-01-07 00:00:00 ET · period of report 2022-01-04 · accession 0001104659-22-002361 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2022-01-07	2022-01-04+	TGTX	Power Sean A	CFO, Sec, Treas	S - Sale	$19.10	-85.0K	568.5K	-13%	-$1.62M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	COMMON STOCK	2022-01-04	S	D	75,312	$19.20	578,136	D	—	—	(F1) In connection with the vesting of 160,000 shares on January 1, 2022, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
2	Common	COMMON STOCK	2022-01-05	S	D	9,653	$18.31	568,483	D	—	—	(F1) In connection with the vesting of 160,000 shares on January 1, 2022, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock. (F2) Includes shares of restricted Common Stock, which are subject to vesting and 140,000 shares of TG Therapeutics stock issuable pursuant to stock options that are currently exercisable or exercisable within 60 days of this filing.